2cureX Feed

2025-07-11 21:10:00 Improved communication from 2cureX AB

2025-07-02 13:19:00 Correction: CEO Nathaniel Hutley presents latest news from 2cureX on July 2nd 2025. 4,00 SEK | +12,99%

2025-07-01 14:25:00 2cureX AB is in the process of securing a strategic collaboration with PreComb Therapeutics AG. 3,54 SEK | +13,10%

2025-06-27 22:35:00 KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)

2025-06-13 14:15:00 CEO Nathaniel Hutley presents latest news from 2cureX on July 2nd 2025. 4,44 SEK | -2,20%

2025-05-30 13:30:00 NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (publ). 2,42 SEK | +21,91%

2025-05-30 13:30:00 KALLELSE TILL ÅRSSTÄMMA I 2CUREX AB (publ). 2,42 SEK | +21,91%

2025-05-29 17:30:00 RELEASE OF THE 2CUREX AB (PUBL) ANNUAL REPORT 2,42 SEK | +21,91%

2025-05-29 17:30:00 PUBLICERING AV ÅRSREDOVISNINGEN FÖR 2CUREX AB (PUBL) 2,42 SEK | +21,91%

2025-05-22 09:15:00 2cureX appoints Mangold Fondkommission AB as new Certified Adviser 2,00 SEK | +3,09%

2025-05-20 10:00:00 2cureX Conducts First Direct-to-Patient IndiTreat® Test Under “Operation Twin Code” Strategy 1,74 SEK | +1,76%

2025-05-15 17:20:00 2cureX AB (2CUREX) Launches “Operation Twin Code” with New Investors, Leadership Transition, and Global Roadmap 1,97 SEK | -2,96%

2025-04-14 12:00:00 EARLY NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (publ) 1,52 SEK | +336,78%

2025-02-27 13:00:00 2cureX publishes interim report for the second half year of 2024 0,40 SEK | -4,08%

2025-01-20 16:00:00 2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE 0,38 SEK | +5,83%

2025-01-10 16:00:00 Correction: 2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE 0,42 SEK | 0,00%

2025-01-10 14:00:00 2CUREX APPOINTS MANGOLD CORPORATE FINANCE TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE 0,42 SEK | 0,00%

2024-12-18 19:15:00 BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL) 0,41 SEK | +2,51%

2024-12-18 19:15:00 KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL) 0,41 SEK | +2,51%

2024-12-16 13:00:00 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of commercial expansion of breakthrough precision oncology products 0,45 SEK | +2,71%

2024-11-29 15:00:00 NOTICE OF EXTRA GENERAL MEETING IN 2CUREX AB 0,47 SEK | +12,98%

2024-11-29 15:00:00 KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB 0,47 SEK | +12,98%

2024-09-24 19:45:00 BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL) 0,64 SEK | +6,67%

2024-09-24 19:45:00 KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL) 0,64 SEK | +6,67%

2024-09-09 12:30:00 Invitation to 2cureX Webcast with Q&A on 24 September 2024 0,49 SEK | -0,41%

2024-09-04 08:45:00 NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBKL) 0,49 SEK | +12,79%

2024-08-22 13:00:00 2cureX publishes interim report for the first half year of 2024 0,51 SEK | +19,67%

2024-07-12 18:00:00 KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

2024-07-01 17:35:00 KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL) 0,51 SEK | +3,06%

2024-06-28 15:00:00 PUBLICERING AV ÅRSREDOVISNINGEN FÖR 2CUREX AB (PUBL) 0,49 SEK | -12,50%

2024-06-28 15:00:00 RELEASE OF THE 2CUREX AB (PUBL) ANNUAL REPORT 0,49 SEK | -12,50%

2024-06-26 16:15:00 EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL) 0,49 SEK | -20,97%

2024-06-26 16:15:00 EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL) 0,49 SEK | -20,97%

2024-06-18 13:45:00 2CUREX APPOINTS OLE THASTRUP AS NEW CEO 0,60 SEK | +129,01%

2024-06-18 00:05:00 Correction: 2CUREX AB ABORTS DELISTING AND ANNOUNCES DIRECTED SHARE ISSUE TO A PRIVATE INVESTMENT COMPANY AND SALE OF THE SUBSIDIARY 2CUREX A/S 0,26 SEK | +0,77%

2024-06-17 23:45:00 2CUREX AB ABORTS DELISTING AND ANNOUNCES DIRECTED SHARE ISSUE TO A PRIVATE INVESTMENT COMPANY AND SALE OF THE SUBSIDIARY 2CUREX A/S 0,60 SEK | +129,01%

2024-05-29 14:30:00 NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (PUBL) 0,31 SEK | -17,55%

2024-05-29 14:30:00 KALLELSE TILL ÅRSSTÄMMA I 2CUREX AB (PUBL) 0,31 SEK | -17,55%

2024-05-29 14:16:00 Correction: Revised Financial Calendar Announcement 0,31 SEK | -17,55%

2024-05-29 14:10:00 Correction: Revised Financial Calendar Announcement 0,31 SEK | -17,55%

2024-05-27 21:45:00 Revised Financial Calendar Announcement 0,38 SEK | -6,00%

2024-05-07 10:35:00 2CUREX AB (PUBL) HAS DECIDED TO APPLY FOR A DELISTING OF ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IN STOCKHOLM – EXPECTED LAST DAY OF TRADING BY END OF JUNE 0,32 SEK | -18,16%

2024-03-16 17:00:00 2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS 0,69 SEK | -45,67%

2024-02-29 16:00:00 KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL) 1,58 SEK | +9,31%

2024-02-29 16:00:00 BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL) 1,58 SEK | +9,31%

2024-02-22 14:45:00 2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024 1,80 SEK | -2,17%

2024-02-12 14:00:00 NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL) 1,78 SEK | -0,83%

2024-02-12 14:00:00 KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL) 1,78 SEK | -0,83%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2cureX

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden